Institutional investors purchased a net $15.9 million shares of ABT during the quarter ended December 2016 and now own 77.70% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Medical Specialties industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
GOLDMAN SACHS & CO. (PRIVATE BAN... Bought 4.0 Million shares of Abbott Laboratories
RENAISSANCE TECHNOLOGIES LLC Bought 3.5 Million shares of Abbott Laboratories
DIMENSIONAL FUND ADVISORS LP Bought 3.0 Million shares of Abbott Laboratories